Meta-analysis backs broader use of BP therapy in CKD
A recent study conducted by Guyu Zeng and colleagues and published in The Lancet highlighted that lowering blood pressure (BP) …
Post
-
-
The strategic investments expanding CDMO capabilities for HPAPIs and ADCs
As oncology pipelines continue to expand and targeted therapies become more sophisticated, contract development and manufacturing organisations (CDMOs) must invest …
-
FDA launches pilot for real-time clinical trials
The US Food and Drug Administration (FDA) is launching a pilot to implement real-time clinical trials (RTCT). While announcing the pilot, …
-
Argo Biopharma begins dosing for Phase I BW-50218 trial
Argo Biopharmaceutical (Argo Biopharma) has dosed the first subject in its Phase I clinical trial assessing BW-50218, a small-interfering ribonucleic …
-
EnteroBiotix nets $25m to progress microbiome-based IBS drug
Investors have gone with their gut on EnteroBiotix’s microbiome-based lead therapy, EBX-102-02, pledging £19m ($25m) to fund a mid-stage trial …
-
EnteroBiotix nets $25m to progress microbiome-based IBS drug
Investors have gone with their gut on EnteroBiotix’s microbiome-based lead therapy, EBX-102-02, pledging £19m ($25m) to fund a mid-stage trial …
-
Massive Bio partners with OpenAI to broaden clinical trial access
Massive Bio has entered a partnership with OpenAI to expand global access to clinical studies through AI-driven parameterisation of protocols …
-
Veradermics’ stock grows on pivotal hair loss win
Veradermics’ share price has jumped more than 47% after its oral, extended-release version of minoxidil posted a win during a …
-
Compass Therapeutics’s stock crashes after OS miss in BTC trial
Compass Therapeutics’ stock has dropped by more than 60% after a Phase II/III trial of its biliary tract cancer (BTC) …
-
Cellenkos receives FDA approval for CK0801 Phase II clinical trial
Cellenkos has received the US Food and Drug Administration (FDA) clearance to begin its Phase II clinical trial of CK0801 …
-
Study finds dose-response relationship between gestational age and autism risk
April is Autism Awareness Month, dedicated to increasing understanding, broadening opportunities, and creating change for people with autism spectrum disorder …
-
Oruka reports positive data from Phase IIa trial for plaque psoriasis
Oruka Therapeutics has reported positive interim data from the ongoing EVERLAST-A Phase IIa trial evaluating ORKA-001 in patients with moderate-to-severe …
-
HRS 2026: Medtronic, Boston Scientific and Abbott debut key PFA data
Boston Scientific, Abbott and Medtronic all presented successful readouts of their cardiac devices during the Heart Rhythm Society’s (HRS) 2026 …
-
Malaria vector Anopheles (Nyssorhynchus) darlingi evolving insecticide resistance
Malaria is a bloodborne parasitic disease wherein Plasmodium parasites are transmitted by mosquito vectors. Despite efforts to control mosquito populations, …
-
ESCMID Global 2026: Pritelivir excels in immunocompromised refractory HSV patients
At the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026 conference, Phase III data for Aicuris’s pritelivir, …
